These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 21350875)

  • 41. The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.
    Stamatovic L; Susnjar S; Gavrilovic D; Minic I; Ursulovic T; Dzodic R
    J BUON; 2018; 23(5):1273-1280. PubMed ID: 30570847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase II study of vinorelbine and docetaxel in the treatment of advanced non-small-cell lung cancer as frontline and second-line therapy.
    William WN; Khuri FR; Fossella FV; Glisson BS; Zinner RG; Lee JJ; Herbst RS; Lippman SM; Kim ES
    Am J Clin Oncol; 2010 Apr; 33(2):148-52. PubMed ID: 19687727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concurrent bevacizumab with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy for HER2- locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.
    Rastogi P; Buyse ME; Swain SM; Jacobs SA; Robidoux A; Liepman MK; Pajon ER; Dy PA; Posada JG; Melnik MK; Piette F; Geyer CE; Mamounas EP; Wolmark N
    Clin Breast Cancer; 2011 Aug; 11(4):228-34. PubMed ID: 21684812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gemcitabine in combination with vinorelbine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer.
    Dong N; Wang M; Li H; Cui Y; Guo Q
    Cancer Chemother Pharmacol; 2012 May; 69(5):1315-22. PubMed ID: 22307763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group.
    Nicolaides C; Dimopoulos MA; Samantas E; Bafaloukos D; Kalofonos C; Fountzilas G; Razi E; Kosmidis P; Pavlidis N
    Ann Oncol; 2000 Jul; 11(7):873-5. PubMed ID: 10997817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low dose gemcitabine plus cisplatin in a weekly-based regimen as salvage therapy for relapsed breast cancer after taxane-anthracycline-containing regimens.
    Sánchez-Escribano Morcuende R; Alés-Martínez JE; Aramburo González PM
    Clin Transl Oncol; 2007 Jul; 9(7):459-64. PubMed ID: 17652060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study.
    Chen J; Yao Q; Li D; Zhang J; Wang T; Yu M; Zhou X; Huan Y; Wang J; Wang L
    BMC Cancer; 2013 May; 13():248. PubMed ID: 23693018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined neoadjuvant chemotherapy with bevacizumab improves pathologic complete response in patients with hormone receptor negative operable or locally advanced breast cancer.
    Makhoul I; Klimberg VS; Korourian S; Henry-Tillman RS; Siegel ER; Westbrook KC; Hutchins LF
    Am J Clin Oncol; 2015 Feb; 38(1):74-9. PubMed ID: 23563210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study.
    Donadio M; Ardine M; Berruti A; Ritorto G; Fea E; Mistrangelo M; Coccorullo Z; Bergnolo P; Comandone A; Bertetto O
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):147-52. PubMed ID: 12764672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A study of the combination of vinorelbine and epirubicin as neoadjuvant chemotherapy regimen in the treatment of locally advanced breast cancer].
    Chen CM; Shen KW; Liu GY; Wu J; Lu JS; Zhuang CJ; Han QX; Liu BL; Shao ZM; Shen ZZ
    Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):745-7. PubMed ID: 16836921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: a minnie pearl cancer research network phase II trial.
    Hainsworth JD; Burris HA; Litchy S; Erland JB; Hon JK; Brierre JE; Greco FA
    Cancer; 2000 Mar; 88(6):1353-8. PubMed ID: 10717616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A phase II study of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer.
    Shehata S; Saad E; Goda Y; El-Mesidi S; Koheil H; Elzawhri H; Kandeel A; Abdelhamid T; Zaki M; Meshref M
    Hematol Oncol Stem Cell Ther; 2010; 3(1):1-6. PubMed ID: 20231807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biweekly docetaxel and vinorelbine as first-line chemotherapy in metastatic breast cancer.
    Mayordomo JI; Milla A; Morales S; Yubero A; Lorenzo A; Baena JM; Modolell A; Sanz J; Illarramendi J; Garcia MJ; Machengs I; Burrilo MA; Tres A
    Clin Breast Cancer; 2004 Jun; 5(2):131-5. PubMed ID: 15245617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gemcitabine/vinorelbine in metastatic breast cancer patients previously treated with anthracyclines: results of a phase II trial.
    Lobo F; Virizuela JA; Dorta FJ; Florián J; Lomas M; Jiménez E; López P; Casado V; Léon A; Estévez LG; Dómine M;
    Clin Breast Cancer; 2003 Apr; 4(1):46-50. PubMed ID: 12744758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II study of neoadjuvant gemcitabine, pegylated liposomal doxorubicin, and docetaxel in locally advanced breast cancer.
    Artioli G; Mocellin S; Borgato L; Cappetta A; Bozza F; Zavagno G; Zovato S; Marchet A; Pastorelli D
    Anticancer Res; 2010 Sep; 30(9):3817-21. PubMed ID: 20944176
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gemcitabine and vinorelbine combination in patients with metastatic breast cancer.
    Sanal SM; Gokmen E; Karabulut B; Sezgin C
    Breast J; 2002; 8(3):171-6. PubMed ID: 12047474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rationale for the use of gemcitabine in breast cancer (Review).
    Silvestris N; D'Aprile M; Andreola G; Locopo N; Marini L; Crucitta E; De Lena M; Lorusso V
    Int J Oncol; 2004 Feb; 24(2):389-98. PubMed ID: 14719116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study.
    Estévez LG; Sánchez-Rovira P; Dómine M; León A; Calvo I; Jaén A; Casado V; Rubio G; Díaz M; Miró C; Lobo F; Carrasco E; Casillas M; San Antonio B
    Clin Transl Oncol; 2007 May; 9(5):317-22. PubMed ID: 17525042
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy.
    Chen YM; Perng RP; Lee CS; Lin WC; Tsai CM; Whang-Peng J
    Am J Clin Oncol; 2003 Dec; 26(6):567-70. PubMed ID: 14663373
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of response by breast helical computed tomography to neoadjuvant chemotherapy in large inflammatory breast cancer.
    Moyses B; Haegele P; Rodier JF; Lehmann S; Petit T; Velten M; Schraub S
    Clin Breast Cancer; 2002 Jan; 2(4):304-10. PubMed ID: 11899363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.